Labshake search
Citations for Tocris :
251 - 300 of 1598 citations for 1 2 Dihydro 1 2 tetrahydro 2H pyran 2 yl oxy ethyl 5H tetrazole 5 thione d4 since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2023Quote: ... and 2 µM ZK 20075 (Tocris, 2345) and moved into a 30 ˚C ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 μM XAV939 (Tocris Bioscience, Bristol, UK), and 3 μg/ml doxycycline (Sigma) ...
-
bioRxiv - Bioengineering 2022Quote: ... the Wnt inhibitor IWP2 (2□uM, TOCRIS) and rhVEGF (10□ng/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 μM Y27632 (129830-38-2, Tocris), 10 nM of Rho Activator II CN03 (Cytoskeleton ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2 μM A-83 (Tocris, 692). After 7 days ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 CaCl2 and 4 MNI-glutamate (Tocris). aCSF was continually bubbled with 95%O2 and 5%CO2 ...
-
bioRxiv - Bioengineering 2023Quote: ... or 2 mg of VP (Tocris Bioscience) was dissolved in 1 mL of DCM containing PLGA ...
-
bioRxiv - Cell Biology 2024Quote: ... and 2 μM XAV-939 (Xav; Tocris). From day 6 ...
-
bioRxiv - Biophysics 2024Quote: ... and 2 µM ZK 20075 (Tocris, 2345) were added to cells 12 – 24 hours post-induction ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2 μM Dorsomorphin dihydrochloride (Tocris/fisher). On day 6 ...
-
bioRxiv - Genomics 2024Quote: ... 2 uM Way-316606 hydrochloride (Tocris, 4767) or vehicle control (DMSO) ...
-
bioRxiv - Neuroscience 2021Quote: ... Eye movements were prevented by injection of a-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Developmental Biology 2021Quote: ... paraxial mesoderm (1 day; 20 ng/ml FGF2, 3 µM CHIR99021, 2 µM SB505124 [cat. num. 3263; Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... Eye movements were prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Neuroscience 2020Quote: ... Eye movements were prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Biochemistry 2021Quote: ... cells were treated with either DMSO or 1 µM of LRRK2 kinase inhibitor (MLi-2, cat.no. 5756, TOCRIS) for 90 mins and then examined for localization ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2024Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 2-[[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy) phenyl]-2-pyridinyl]thio]-acetamide (BAY 60-6583; Tocris, 910487-58-0), 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide (2-Chloro-IB-MECA ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 mM stock made in water) and 2 mM 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI caged glutamate) (Tocris Bioscience ...
-
bioRxiv - Physiology 2021Quote: ... resiniferatoxin and 4-(3-Chloro-2-pyridinyl)-N-[4-(1,1-dimethylethyl)phenyl]-1-piperazinecarboxamide (BCTC) were purchased from Tocris Bioscience or Adooq Bioscience and stock solutions were prepared in EtOH at 1 M and 100 mM ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... adrenergic agonist Xylazine Chloride (XYL, 2% m.V-1, Anasedan®) and opioid agonist Ala2-MePhe4-Gliol5-encephalin (DAMGO, Tocris) and their specified doses were diluted to a final injection volume of 20µL either in sterile NaCl 0,9% m.V-1 (saline ...
-
bioRxiv - Neuroscience 2024Quote: ... Eye movements were further prevented by injection of α-bungarotoxin (1 nL of 2 mg/ml; Tocris, Cat: 2133) into the ocular muscles behind the eye.
-
bioRxiv - Neuroscience 2021Quote: ... 2-APB was purchased from Tocris (Bristol, UK). All other chemicals were purchased from Sigma (St ...
-
bioRxiv - Neuroscience 2020Quote: ... This was followed by Ionomycin (2 µM) (Tocris) as a positive control and to set the Fmax ...
-
bioRxiv - Animal Behavior and Cognition 2022Quote: ... biocytin (2 mg/ml; Tocris Bioscience, Bristol, UK) was added into the internal solution ...
-
bioRxiv - Cell Biology 2022Quote: ... EIPA (1154-25-2) was obtained from TOCRIS. MK2206 (A3010 ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 2 µM of Gö6983 (Cat. 2285, Tocris), as previously described9 ...
-
bioRxiv - Neuroscience 2020Quote: ... AMPAR antagonists ZK200775 (2 nM, Tocris, Cat# 2345) and kynurenic acid (0.1 mM ...
-
bioRxiv - Cell Biology 2022Quote: ... 2 μM Latrunculin A (Cat. No. 3973, Tocris) was added to the media bath ...
-
bioRxiv - Genomics 2022Quote: ... 1μm Mek1/2 Inhibitor (PD0325901) (Tocris, Cat#: 4192) and 3μm GSK3a/b inhibitor (CHIR99021 ...
-
bioRxiv - Neuroscience 2020Quote: MPEP (2-Methyl-6-(phenylethynyl)pyridine) from Tocris
-
bioRxiv - Cell Biology 2020Quote: MLi-2 LRRK2 inhibitor was obtained from Tocris Biosciences (Cat ...
-
bioRxiv - Neuroscience 2023Quote: ... For MLi-2 (Tocris Bioscience; catalog no. 5756) and Conduritol B Epoxide (MERK ...
-
bioRxiv - Physiology 2023Quote: ... 2 µM AR-C155858 (Tocris, Cat. No. 4960), 4 µM Shikonin (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... AMPAR antagonists ZK200775 (2 nM, Tocris, Cat# 2345) and kynurenic acid (0.1 mM ...
-
bioRxiv - Molecular Biology 2022Quote: ... 2 µM A-83-01 (Tocris, Cat# 2939). Following initial seeding of the cultures ...
-
bioRxiv - Cell Biology 2024Quote: ... MLi-2 (Tocris, 5756; and MedChemExpress, HY-100411) was used at 1 μM in DMSO for 90 min prior to LLOME incubation ...
-
bioRxiv - Molecular Biology 2023Quote: ... 2 and 10 μM pyridostatin (PDS; Tocris Bioscience) for 30 min at 30°C ...
-
bioRxiv - Molecular Biology 2023Quote: ... 2 nM MC903 (R&D, Tocris, MN, USA) dissolved in ethanol or ethanol as control were topically applied daily for a period of 14 days ...
-
bioRxiv - Molecular Biology 2023Quote: ... cells were treated with 2 μM UNC1999 (Tocris) for at least one week ...
-
bioRxiv - Neuroscience 2022Quote: ... injection of either ghrelin (2 mg/kg; Tocris) or vehicle control (phosphate-buffered saline ...
-
bioRxiv - Neuroscience 2023Quote: ... S2618)+10 µM SB431542 +2 µM XAV939 (TOCRIS, 3748). On day 2 ...
-
bioRxiv - Neuroscience 2023Quote: Mice were randomly assigned for MLi-2 (Tocris) or vehicle treatment (Captisol) ...
-
bioRxiv - Neuroscience 2024Quote: ... 2 μM of CGP55845 (GABABR blocker; 1248, Tocris), 10 μM of DPCPX (antagonist of A1 adenosine receptors ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2 μM ω-conotoxin GVIA (Tocris, 1085). These were added before ...
-
bioRxiv - Neuroscience 2024Quote: ... The MCT1/2 inhibitor AR-C155858 (24) (Tocris) was prepared fresh for each experiment and was diluted to a final concentration of 50 µM in ACSF and applied via the perfusion line during baseline recordings ...
-
bioRxiv - Neuroscience 2024Quote: ... endocannabinoid agonist WIN 55,212-2 (5μM) (Tocris Bioscience) was bath-applied and after a resting period of 15 min ...
-
bioRxiv - Cancer Biology 2024Quote: ... mice were randomized into groups and treated daily (5 days on, 2 days off) with 1mg/kg SB290157 trifluoroacetate (Tocris, 6860/5) intra-peritoneally ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... the α4-selective nAChR antagonist dihydro-β-erythroidine hydrobromide (DHβE; 5 mg/kg in sterile saline; Tocris, Bristol, UK), or the α7-selective nAChR antagonist methyllycaconitine citrate (MLA ...